Pooled week 48 safety and efficacy results from the ECHO and THRIVE phase III trials comparing TMC278 vs EFV in treatment-nave, HIV-1-infected patients
本文档由 567721 分享于2015-12-21 22:31
Pooled week 48 safety and efficacy results from the ECHO and THRIVE phase III trials comparing TMC278 vs EFV in treatment-nave, HIV-1-infected patients
分享：
君，已阅读到文档的结尾了呢~~